Nick has a passion for providing clients with data-driven strategic insights on their most challenging business questions. His background in early commercial strategy and commercialization with a wide array of clients has given him a deep understanding of the pharmaceutical landscape.
Nick’s experience covers a broad range of therapeutic areas and the commercial development spectrum, with a focus on oncology, and cell and gene therapy. Recent engagements of note include creating commercially viable clinical development plans for early stage assets, product strategy and franchise planning of an oncology portfolio, and commercialization of a gene therapy. Clients have commended Nick on his grasp and understanding of key strategic issues, and pragmatic approach to problem solving when working with novel commercial assets.
In addition to his commercialization experience, Nick also possesses extensive experience leading market research efforts with a variety of stakeholders, including physicians, payers, and patients through tele-depth interviews and advisory boards. Prior to joining Blue Fin Group, Nick was a Senior Consultant at Artisan Healthcare Consulting.